Physician profile
Asker E Asmi
NPI 1649240177
$11,034.68
in general payments reported to CMS, 2019-2025
46 companies · $1,814 in 2025
The $1,814 reported for 2025 was more than what 85% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $749 · 2021: $1,639 · 2022: $2,223 · 2023: $2,024 · 2024: $1,457 · 2025: $1,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,171 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,171.37 |
| Education | $124.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,588.28 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Mylan Specialty L.P. | $1,448.94 | 2019-2024 | Yupelri, Yupelri |
| Glaxosmithkline, LLC. | $1,338.68 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,304.44 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $654.21 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $391.72 | 2020-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $378.04 | 2021-2025 | Glassia |
| Baxter Healthcare | $353.04 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $347.13 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $325.39 | 2020-2025 | |
| Harmony Biosciences LLC | $316.77 | 2022-2025 | Wakix |
| Sunovion Pharmaceuticals INC. | $274.12 | 2019-2020 | |
| United Therapeutics Corporation | $269.67 | 2020-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $180.54 | 2019-2025 | Opsumit, Uptravi |
| Inogen, INC. | $164.96 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $133.46 | 2024 | Purified Cortrophin Gel |
| Electromed, INC. | $132.93 | 2021-2025 | Smartvest |
| Advanced Respiratory, INC | $124.58 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $121.44 | 2019-2025 | |
| Pulmonx Corporation | $103.58 | 2021-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $102.90 | 2020-2025 | Acthar |
| Avadel Cns Pharmaceuticals, LLC | $99.71 | 2023-2024 | Lumryz |
| Axsome Therapeutics, INC. | $95.60 | 2023-2025 | Sunosi |
| Genentech USA, INC. | $81.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $76.95 | 2020-2023 | |
| Philips North America LLC | $74.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $60.67 | 2019-2020 | |
| Inspire Medical Systems, INC. | $47.67 | 2023-2024 | Inspire |
| Teva Pharmaceuticals USA, INC. | $40.45 | 2021 | |
| Circassia INC. | $40.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.54 | 2019-2023 | |
| Mallinckrodt Enterprises LLC | $31.15 | 2019 | |
| Shire North American Group INC | $29.06 | 2019 | |
| Resmed Corp | $28.46 | 2020 | |
| Abbvie INC. | $26.62 | 2022 | |
| Vapotherm INC | $24.73 | 2022 | |
| Amgen INC. | $21.62 | 2025 | Tezspire |
| Viatris Specialty LLC | $20.83 | 2025 | Yupelri |
| Azurity Pharmaceuticals, INC. | $20.24 | 2024 | Horizant |
| Portola Pharmaceuticals, LLC | $19.94 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.81 | 2024 | Quviviq |
| Zoll Respicardia, INC. | $18.26 | 2024 | Remede System |
| Verona Pharma, INC. | $17.68 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $16.89 | 2025 | Zepbound |
| Pfizer INC. | $16.32 | 2023 | |
| Csl Behring | $15.00 | 2025 | Hizentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asker Asmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.